Login

Jungheinrich CEO: From Challenges to Comeback | Lars Brzoska - CEO of Jungheinrich 00:10:00

Share On Facebook Share On Twitter

Lars Brzoska is Chairman-Mgmt Board/CEO at Jungheinrich AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Practicing emergency physician / John D. Halamka, MD, MS Professor of Medicine Harvard Medical School
00:10:00
Alvotech's Integrated Approach and Expansive Pipeline Energize Pharmaceutical Markets Worldwide|Róbert Wessman, CEO, Alvotech SA.
00:10:00
Redefining Financial Advisory: Beyond Investments | Alex Johnson, Founder and Financial Advisor, Oakview Wealth Management
00:10:00
Alberto Orozco on Capitan Mining's Exploration Endeavors at Cruzero Plata Project in Durango, Mexico
00:10:00
Empowering Change: Manulife's Commitment to Climate Action | Roy Gori, CEO , Manulife Investment Management.
00:10:00
Dundee's Arsenic Stabilization: Converting Toxic Waste into Safe, Long-Lasting Glass
00:10:00
Thaicom CEO Suphajee Suthumpun discusses the convergence of satellite, broadcasting, and broadband technologies.
00:10:00
Filo Mining: Advancing the Filo del Sol Project in South America
00:10:00
Mines and Money Global Spotlights PYX Resources and Its Key Projects | Oliver Hasler, Chairman , PYX Resources Ltd.
00:10:00
Transformational technologies that create longterm economic and societal value|Bhaskar BG Ghosh,CTO,8VC
00:10:00
Gene Sheridan, Co-Founder and CEO of Navitas Semiconductor, delves into the influence of AI on the semiconductor industry.|Gene Sheridan, CEO of Navitas Semiconductor
00:10:00
Jeff Bezos In 1999 On Amazon's Plans Before The Dotcom Crash

© 2017 - Neuhu+